SciTransfer
Organization

HENDRIX GENETICS RESEARCH,TECHNOLOGY & SERVICES BV

Commercial animal genetics company bridging poultry and swine breeding with welfare science and functional genomics research.

Large industrial companyfoodNLNo active H2020 projectsThin data (2/5)
H2020 projects
2
As coordinator
0
Total EC funding
€587K
Unique partners
30
What they do

Their core work

Hendrix Genetics is a global animal genetics company whose research arm applies scientific tools to practical livestock breeding challenges in poultry and swine. They bring commercial breeding industry expertise into academic consortia — contributing proprietary data, animal populations, and applied knowledge that pure research institutions cannot replicate. In both their H2020 projects, they served as the industry bridge: providing access to commercial laying hen and pig genetics while anchoring research in real production environments. Their R&D division spans behavioural and welfare science as well as functional genomics, positioning them at the intersection of animal biology and precision breeding.

Core expertise

What they specialise in

Poultry welfare and stress physiologyprimary
1 project

CHICKENSTRESS investigated variation in stress responsivity in laying hens to match bird genotypes with housing environments, directly relevant to Hendrix Genetics' commercial egg-production breeding lines.

Livestock functional genomicsprimary
1 project

GENE-SWitCH mapped regulatory elements in the swine and chicken genome during development, requiring access to the commercial genetic diversity that Hendrix Genetics maintains.

Genotype-to-phenotype translation in monogastricssecondary
1 project

GENE-SWitCH explicitly targets functional annotation to bridge genomic sequence and measurable traits in pigs and chickens — the core scientific problem in commercial animal breeding.

Applied animal breeding and commercial geneticsprimary
2 projects

Both projects rely on Hendrix Genetics' role as an industry partner supplying commercial breeding populations and applied context across poultry (both projects) and swine (GENE-SWitCH).

Evolution & trajectory

How they've shifted over time

Early focus
Poultry welfare and stress behaviour
Recent focus
Regulatory genomics in swine and chicken

Both projects launched in 2019, so there is no chronological separation to draw a timeline from. However, the keyword grouping reveals two distinct research tracks running in parallel: one anchored in observable animal behaviour and production outcomes (stress responsivity, egg production), and another in the molecular machinery underneath those traits (regulatory elements, functional annotation, genotype-to-phenotype mapping). This suggests that Hendrix Genetics' R&D strategy deliberately spans both the phenotypic and genomic layers — welfare performance on one side, the genetic architecture explaining it on the other. For a breeding company, that combination is strategically coherent: welfare traits need both measurement science and the genomic tools to select for them efficiently.

Hendrix Genetics is deepening from phenotypic welfare research into the genomic foundations of production traits, pointing toward future partnerships in precision livestock breeding, genomic selection, and gene regulation in farm animals.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European13 countries collaborated

Hendrix Genetics participates exclusively as a consortium partner — never as coordinator — which is consistent with a large industry company that contributes unique assets (commercial animal populations, breeding data, applied expertise) rather than administrative leadership. With 30 distinct partners across 13 countries from just two projects, they work inside sizeable multi-partner consortia, suggesting comfort with complex academic-industry arrangements. This profile is typical of an industry player that adds credibility and real-world relevance to research projects rather than driving their scientific agenda.

Hendrix Genetics has connected with 30 unique partners across 13 countries through just two projects — an unusually broad network for such a small project portfolio, reflecting the large consortium structures of both MSCA-ITN and RIA instruments. Their reach is pan-European with no obvious geographic concentration.

Why partner with them

What sets them apart

Hendrix Genetics is one of very few large commercial animal genetics companies actively engaged in EU-funded research, giving them a rare dual identity: credible industrial partner for livestock projects and a company whose proprietary breeding populations and commercial-scale data are genuinely irreplaceable in academic consortia. For a consortium building around poultry or swine genomics, welfare, or breeding technology, they bring the industry validation and real animal material that makes research outcomes immediately translatable. No university or research institute can substitute for a partner that owns commercial breeding lines at scale.

Notable projects

Highlights from their portfolio

  • GENE-SWitCH
    The largest of their two funded projects (EUR 320,998) and scientifically ambitious — mapping the functional regulatory genome of both swine and chicken during development, which directly underpins the next generation of genomic selection tools in commercial breeding.
  • CHICKENSTRESS
    An MSCA Innovative Training Network on stress responsivity in laying hens — notable because it links animal welfare science directly to commercial egg production genetics, an area where Hendrix Genetics is a global market player.
Cross-sector capabilities
Animal welfare science and behavioural biologyFunctional genomics and regulatory element annotationPrecision breeding and genomic selection methodology
Analysis note: Only two projects, both starting in the same year (2019), limit the reliability of any evolutionary trend analysis. The early vs. recent keyword split reflects project topics rather than genuine temporal change. Profile confidence in current expertise areas is reasonable, but the organisation's full R&D scope — given their size as a global genetics company — is almost certainly broader than what two EU projects reveal.